IL1A and diabetes mellitus: Nonetheless, recombinant IL-1RA (Anakinra) has been found to be beneficial in animal models (284) of diabetes and patients with diabetes (285), suggesting that excess IL-1 signaling contributes to beta cell damage in diabetes (286).